Apply For Grant Funding
Call for Proposals — Lobular Carcinoma
Breast Cancer Canada is now accepting applications for the 2026 Research Grant Competition, awarding a total of $250,000 CAD to accelerate precision oncology in Lobular Carcinoma breast cancer. This national grant program is designed to fuel innovation in precision diagnostics and targeted treatment driven by Canadian research teams who are shaping the future of breast cancer care.
Key Dates
| Milestone | Deadline |
|---|---|
| Applications Open | October 20, 2025 |
| Letter of Intent (LOI) Due | December 12, 2025 – 5 PM PT |
| Letter of Invitation Issued by BCC | December 19, 2025 |
| Grant Proposal (NOI) Due | February 13, 2026 – 5 PM PT |
| Notice of Decision Issued by BCC | April 17, 2026 |
| Grant Announcement | May 2026 at ASCO Congress (BCC event date TBC) |
| Funding Start | June 30, 2026 |
Click here to begin your Letter of Intent (LOI)
Submissions are accepted by email to research@breastcancerprogress.ca
This competitive grant program supports Canadian-led research projects with a strong focus on precision oncology, AI-driven innovation, and patient partnership. Projects must be grounded in science, data, and lived experience, with active engagement from a breast cancer patient advocate—ideally someone diagnosed with Lobular Carcinoma.
Two grant tiers are available. Applicants may select their Core Focus Area and Budget Category:
| Research Focus | Budget Category 1 | Budget Category 2 |
|---|---|---|
| Targeted Diagnostics (Screening, Detection, or Follow-up) | $75,000 (3 x $25,000 annually) | $50,000 (2 x $25,000 annually) |
| Targeted Treatment (Surgery, Medicine, or Radiation) | $75,000 (3 x $25,000 annually) | $50,000 (2 x $25,000 annually) |
Why You Should Apply
Breast Cancer Canada stands as the sole national organization in Canada exclusively dedicated to advancing breast cancer research. With a steadfast commitment to preci s ion oncology, we focus on developin g personal ized treatment plans tailored to individual patients’ needs. Through strategic funding initiatives, we aim to accelerate the transition from standard treatment approaches to the new era of personal ized medicine, ultimately striving to match the right plan to the right person at the right time.
Exclusive Focus on Precision Oncology
BCC is uniquely dedicated to funding research that advances precision oncology, encompassing areas such as basic science, screening and detection, personalized treatment, and patient-reported outcomes. This targeted approach ensures that funded projects contribute directly to the development of individualized treatment strategies for breast cancer patients.
Diverse and Substantial Funding Opportunities
Researchers have access to a variety of funding programs, including Tier 1 and Tier 2 grants for screening, detection, targeted treatment, and precision diagnostics, with amounts ranging from $50,000 to $75,000 CAD. Additionally, BCC offers specialized grants such as the $1 million Canadian Breast Cancer Cl inical Scienti st Fellows h ip P rog ram and collaborative grants with industry partners like AstraZeneca Canada.
Emphasis on Patient-Centric Research
BCC mandates the inclusion of breast cancer patient advocates or local advocacy groups in funded research projects. This requirement ensures that research remains patient-focused, integrating real-world experiences and perspectives to enhance the relevance and impact of scientific findings.
Proven Track Record of Catalyzing Further Funding
BCC’s seed funding programs, such as the Breast Cancer Canada Translational Research Unit Scholarships Program, have a history of enabling researchers to secure additional funding from government or industry sources. Recipients often leverage initial BCC grants into significantly larger investments, amplifying the reach and potential impact of their research.
The Power of BCC Funding
At Breast Cancer Canada, research grants are more than just financial support—they are catalysts for progress that drive meaningful advancements in breast cancer care. These grants enable scientists and clinicians to pursue innovative research that accelerates the development of more accurate diagnostic tools, less invasive treatment options, and more effective therapies with fewer side effects. Beyond the lab, Breast Cancer Canada’s grant programs also require collaboration with patient advocates, ensuring that research remains grounded in the lived experiences of those affected by the disease. As a result, every grant awarded brings us one step closer to a future where breast cancer is detected earlier, treated more effectively, and understood more completely.
Grant Funding Policy
This policy outlines Breast Cancer Canada’s position on the allocation of research grant funding, with specific reference to indirect and overhead costs.
Progress Through Research
Latest Research
Breast Cancer Canada donations fund life-saving research that directly impacts Canadian patients. That means better answers, bigger breakthroughs – and more personalized treatment for every breast cancer diagnosis.
Patient Tools
Our suite of digital tools are each designed to help individuals better manage their breast cancer journey through education, research and personalized insights, while also elevating the patient voice.
Patient Stories
Every breast cancer journey is unique, but together, these stories paint a powerful picture of progress. Through firsthand accounts from patients and survivors, we share stories that highlight the lived-experiences of breast cancer.
Fuel Progress
Progress happens when we invest in it. Canada is home to some of the world’s brightest minds in research. Together, we are advancing science, ensuring it leads to earlier detection, better treatments, and improved outcomes for patients across the country.
